Calumet, Inc. (NASDAQ:CLMT - Get Free Report) has been given an average recommendation of "Hold" by the eight analysts that are presently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $18.7083.
A number of analysts recently weighed in on CLMT shares. UBS Group boosted their target price on Calumet from $12.00 to $13.25 and gave the stock a "neutral" rating in a research report on Tuesday, August 12th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Calumet in a research note on Wednesday. Finally, Zacks Research cut Calumet from a "hold" rating to a "strong sell" rating in a research note on Tuesday, October 7th.
Check Out Our Latest Analysis on Calumet
Calumet Price Performance
NASDAQ:CLMT opened at $17.68 on Friday. The business has a 50 day moving average of $16.76 and a 200 day moving average of $14.72. The company has a market capitalization of $1.53 billion, a price-to-earnings ratio of -3.39 and a beta of 0.98. Calumet has a 1-year low of $7.68 and a 1-year high of $25.29.
Calumet (NASDAQ:CLMT - Get Free Report) last released its earnings results on Friday, August 8th. The oil and gas company reported ($1.70) earnings per share for the quarter, missing analysts' consensus estimates of ($0.44) by ($1.26). The company had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $982.88 million. Calumet's revenue was down 9.4% compared to the same quarter last year. During the same period last year, the firm earned ($0.48) EPS. As a group, sell-side analysts anticipate that Calumet will post -3.02 EPS for the current year.
Hedge Funds Weigh In On Calumet
A number of large investors have recently bought and sold shares of the stock. Premier Path Wealth Partners LLC increased its stake in Calumet by 11.4% in the 2nd quarter. Premier Path Wealth Partners LLC now owns 12,853 shares of the oil and gas company's stock worth $202,000 after purchasing an additional 1,320 shares during the period. University of Texas Texas AM Investment Management Co. increased its stake in Calumet by 109.4% in the 2nd quarter. University of Texas Texas AM Investment Management Co. now owns 3,350 shares of the oil and gas company's stock worth $53,000 after purchasing an additional 1,750 shares during the period. Amalgamated Bank purchased a new position in Calumet in the 2nd quarter worth approximately $37,000. O Keefe Stevens Advisory Inc. increased its stake in Calumet by 12.1% in the 2nd quarter. O Keefe Stevens Advisory Inc. now owns 26,817 shares of the oil and gas company's stock worth $423,000 after purchasing an additional 2,903 shares during the period. Finally, California State Teachers Retirement System increased its stake in Calumet by 7.3% in the 2nd quarter. California State Teachers Retirement System now owns 63,529 shares of the oil and gas company's stock worth $1,001,000 after purchasing an additional 4,304 shares during the period. 34.41% of the stock is owned by hedge funds and other institutional investors.
About Calumet
(
Get Free Report)
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Calumet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet wasn't on the list.
While Calumet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.